Comparison of yttrium-90 radioembolization and transcatheter arterial chemoembolization for the treatment of unresectable hepatocellular carcinoma.
about
Transarterial radioembolization for hepatocellular carcinoma: a reviewCurrent status of transarterial radioembolizationNew advances in hepatocellular carcinomaTransarterial Radioembolization with Yttrium-90 for the Treatment of Hepatocellular CarcinomaRole of Transcatheter Intra-arterial Therapies for Hepatocellular CarcinomaTransarterial radioembolization using yttrium-90 microspheres in the treatment of hepatocellular carcinoma: a review on clinical utility and developmentsInterventional therapies for hepatocellular carcinomaRadioembolization with Yttrium-90 microspheres in hepatocellular carcinoma: Role and perspectivesSelective Internal Radiation Therapy (SIRT) as Conversion Therapy for Unresectable Primary Liver MalignanciesUpdate in management of hepatocellular carcinoma in Eastern populationTransarterial radioembolization for hepatocellular carcinoma: An update and perspectivesY90 Radioembolization Significantly Prolongs Time to Progression Compared With Chemoembolization in Patients With Hepatocellular CarcinomaUnresectable Hepatocellular Carcinoma: Radioembolization Versus Chemoembolization: A Systematic Review and Meta-analysis.Current management of hepatocellular carcinoma.A multidisciplinary approach to the management of hepatocellular carcinoma.Radiation therapy for liver tumors: ready for inclusion in guidelines?Survival analysis of transarterial radioembolization with yttrium-90 for hepatocellular carcinoma patients with HBV infection.Updates in the management of hepatocellular carcinomaTransarterial therapies for hepatocellular carcinoma.Transarterial embolization therapies for the treatment of hepatocellular carcinoma: CEPO review and clinical recommendationsRadioembolization results in longer time-to-progression and reduced toxicity compared with chemoembolization in patients with hepatocellular carcinoma.The use of transarterial chemoembolization in the treatment of unresectable hepatocellular carcinoma: a response to the Cochrane Collaboration review of 2011Conventional transarterial chemoembolization vs microsphere embolization in hepatocellular carcinoma: a meta-analysis.Radioembolization for primary and metastatic liver cancer.Intermediate hepatocellular carcinoma: How to choose the best treatment modality?Hong Kong consensus recommendations on the management of hepatocellular carcinoma.Yttrium-90 microsphere radioembolization for hepatocellular carcinoma.Interventional radiological treatment of hepatocellular carcinoma: an update.Effective treatment strategies other than sorafenib for the patients with advanced hepatocellular carcinoma invading portal veinRadioembolization with Yttrium-90 microspheres for patients with unresectable hepatocellular carcinoma.Transcatheter intraarterial therapies: rationale and overviewTransarterial radioembolization versus chemoembolization for the treatment of hepatocellular carcinoma (TRACE): study protocol for a randomized controlled trialClinical guideline SEOM: hepatocellular carcinomaDramatic Response of a Large, 10 Cm Hepatocellular Carcinoma to Monotherapy with Yttrium-90 Based Selective Internal Radiation Therapy.Efficacy and safety of transarterial radioembolization versus chemoembolization in patients with hepatocellular carcinoma.Long-term follow-up study of gastroduodenal lesions after radioembolization of hepatic tumorsEffectiveness of Initial Transarterial Chemoembolization for Hepatocellular Carcinoma Among Medicare BeneficiariesConformal external beam radiation or selective internal radiation therapy-a comparison of treatment outcomes for hepatocellular carcinoma.Consensus for Radiotherapy in Hepatocellular Carcinoma from The 5th Asia-Pacific Primary Liver Cancer Expert Meeting (APPLE 2014): Current Practice and Future Clinical Trials.Yttrium-90 Radioembolization in Patients with Hepatocellular Carcinoma Who have Previously Received Sorafenib
P2860
Q26738273-10A351C9-4431-4907-AB4F-C18B29CE4B00Q26744307-B1FF6858-611A-4E31-85AA-C1D97CFBAD8DQ26749329-E14E09D6-CF5F-4390-AD7B-CD5E8D282787Q26753089-7C39A3B2-CDC1-423C-B607-CDD7A1CE89BCQ26851627-A2B6A4F6-AA7B-43D8-A962-C1A59D4882A9Q26852174-62E5EC9F-DF86-48FE-9532-8D8ACDA5DCB1Q26864803-2F55848D-5283-49E7-BFAB-E5D89A5DE871Q27023616-31270811-26D3-46CA-9E0E-6A2EA8EF4F87Q28071594-57262671-C6F9-4984-9CC3-7888D502927DQ28080480-5B5C615B-B6C2-47B3-817D-647F161940E2Q28081783-F32FAE16-50EB-40A5-BE95-AF3FE7C30C2DQ28314897-2A5D2E07-E27B-4417-BDA8-704D2C1D4C50Q30248206-E5865C77-8A84-40B7-8D2F-81E8DDA68D4DQ33582165-81AD8C9A-5AD2-426E-8B16-0AFA7AAA8FB1Q33916361-CE6CA3C3-C46B-4AD4-85AA-C60971F0565EQ34005194-9545257A-BCE3-4B9E-8942-9FC57AE6DA7EQ34077181-830C7023-C2CE-49DB-83E4-F61D9131FFB3Q34571160-74C5ED83-0163-411E-B307-E5DE8A6EF548Q34628257-E754D76B-A035-46CA-BC64-BAC9D8CBB731Q34702094-BB9AC139-654E-4072-872F-C5B9D852BA8DQ35085486-8D83A0A3-D32A-4426-ABC7-AF832AEB9D1FQ35096101-C7C3CDB0-B572-4795-BD0B-888D638B8BB9Q35506937-8B33A500-6749-44FC-AF82-031947FCFA43Q35564038-0B396BD3-A831-49D8-BBD2-81130D007A1CQ35626764-5487C7FA-EF51-4F9B-B0C8-974986A1D969Q35631295-A69E01C6-166C-45FA-A5C3-86B401D33276Q35631304-DD1397A7-626B-4B36-BFEE-A11F4610A711Q35675131-184EF7D1-4951-4300-8B61-E08D90EB47A4Q35715947-6EE1C72B-938B-4DDC-9162-6B869DC193C9Q36062588-09DF9ED8-9C3E-4836-A551-673E1C306349Q36104314-40FED7CF-6DC9-4A10-A622-372E016AA437Q36383875-B92E4B3F-C0DD-4BE4-A284-3A003F324B66Q36400259-8435F67A-5F8D-45E0-B9B9-63495608F4FAQ36505147-B828972F-5800-4AC2-A516-C46F72C43D67Q36673829-D7DCD34C-F2B7-40D4-B5AC-C986627B8191Q36865115-A09C87E7-1A66-4BFC-B66D-57FC054A7493Q36886453-87469BC0-B367-462C-942D-6D9D7A8FF365Q36936990-6FB8AF53-DDFC-4E2F-AF93-79335B02E6ACQ37124697-11315DFC-AA59-491B-B02C-9DDCBEE003C3Q37417900-52436278-51AB-463E-A09A-B008917D8522
P2860
Comparison of yttrium-90 radioembolization and transcatheter arterial chemoembolization for the treatment of unresectable hepatocellular carcinoma.
description
2009 nî lūn-bûn
@nan
2009 թուականի Դեկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2009 թվականի դեկտեմբերին հրատարակված գիտական հոդված
@hy
2009年の論文
@ja
2009年論文
@yue
2009年論文
@zh-hant
2009年論文
@zh-hk
2009年論文
@zh-mo
2009年論文
@zh-tw
2009年论文
@wuu
name
Comparison of yttrium-90 radio ...... able hepatocellular carcinoma.
@ast
Comparison of yttrium-90 radio ...... able hepatocellular carcinoma.
@en
Comparison of yttrium-90 radio ...... able hepatocellular carcinoma.
@nl
type
label
Comparison of yttrium-90 radio ...... able hepatocellular carcinoma.
@ast
Comparison of yttrium-90 radio ...... able hepatocellular carcinoma.
@en
Comparison of yttrium-90 radio ...... able hepatocellular carcinoma.
@nl
prefLabel
Comparison of yttrium-90 radio ...... able hepatocellular carcinoma.
@ast
Comparison of yttrium-90 radio ...... able hepatocellular carcinoma.
@en
Comparison of yttrium-90 radio ...... able hepatocellular carcinoma.
@nl
P2093
P1476
Comparison of yttrium-90 radio ...... able hepatocellular carcinoma.
@en
P2093
Abbas Chamsuddin
Charles A Staley
David A Kooby
Hyun S Kim
Keith A Delman
Swetha Srinivasan
Vasili Egnatashvili
P304
P356
10.1016/J.JVIR.2009.10.013
P577
2009-12-21T00:00:00Z